A Novel Indicator for COVID-19 Pandemic Assessment and Comparison
Mukherjee, K.
Show abstract
IntroductionIn an increasingly globalized world, no country can remain immune to the effect of the COVID-19 pandemic. The pandemic has exposed the need for effective public health surveillance in the interest of global health security. However, current indicators are limited in doing a comparative intercountry assessment and comparison because of variation in testing rates and reporting standards. Hence, this study attempts at addressing this gap. MethodsThe study proposes incremental change in cases per testing rate (ICTR) as an indicator for doing cross country comparison of the pandemic progress. The equation for calculating this indicator is explained in this study. This is followed by measuring its strength of association and predictive power for determining change in SARS-CoV-2 cases in five countries (USA, UK, India, Pakistan and Bangladesh). Results and discussionICTR was found to have a significantly higher strength of association and predictive power (than the existing indicator-test positivity rate) for determining change in cases over different time periods. Using ICTR, cross country comparison was done for the five countries for15 months to draw deeper insights into the progress of the pandemic. ConclusionsThe study finds ICTR to be a suitable indicator for intercountry comparison and intracountry monitoring of the pandemic, which would be useful for global COVID-19 surveillance.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The knowledge and practice towards COVID-19 pandemic prevention among residents of Ethiopia. An online cross-sectional study. 97%
- Community’s misconception about COVID-19 and its associated factors: Evidence from a cross-sectional study in Bangladesh 96%
- Comparative Genomic Study for Revealing the Complete Scenario of COVID-19 Pandemic in Bangladesh 96%
Similar papers in this journal
Similar papers in this journal
- Comparative study between first and second wave of COVID-19 deaths in India - a single center study 95%
- Second wave of the Covid-19 pandemic in Delhi, India: high seroprevalence not a deterrent? 94%
- SARS-CoV-2 seroprevalence in Delhi, India - September-October 2021 – a population based seroepidemiological study 94%
Similar papers in this journal
- Protocol for a prospective, hospital-based registry of pregnant women with SARS-CoV-2 infection in India: PregCovid Registry study 94%
- Risk Factors for Non-Communicable Diseases among Bangladeshi Adults: An Application of Generalized Linear Mixed Model on Multilevel Demographic and Health Survey Data 94%
- COVID-19 Vaccine hesitancy in Addis Ababa, Ethiopia: A mixed-methods study 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.